MIRA Pharmaceuticals, Inc. (MIRA) earnings
MIRA earnings moved a median of -1.82% by the close. Quarterly and annual MIRA reports and results, each read against the price at its own news timestamp. Back to the MIRA overview →
14 measured MIRA earnings events.
Where these MIRA earnings landedvs 13 measured MIRA earnings reactions
| Middle 50% of MIRA earnings reactions | -5.46% to +2.04% |
|---|---|
| Median reaction (to close) | -1.82% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 MIRA earnings events with a measured close landed between -5.46% and +2.04%; 31% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MIRA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +5.51% | +2.75% | |
| Form 10-Q MIRA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | — | -0.40% | |
| Form 10-K MIRA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | — | +0.00% | |
| Form 10-Q MIRA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -0.30% | — | |
| Form 10-Q MIRA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +2.04% | |
| Form 10-Q MIRA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +6.77% | |
| Form 10-K/A MIRA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -1.99% | -7.98% | |
| Form 10-K/A MIRA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -10.02% | -17.05% | |
| Form 10-K MIRA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -3.09% | -6.67% | |
| Form 10-Q MIRA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -4.39% | -5.46% | |
| Form 10-Q/A MIRA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.09% | -5.32% | |
| Form 10-Q MIRA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +2.52% | -2.52% | |
| Form 10-Q MIRA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.54% | |
| Form 10-K MIRA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.01% | -1.82% |
Keep exploring
More MIRA: analyst actions → · SEC filings → · MIRA overview →